Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Vaccines
Filter     Order     Display # 
Date Item Title
10 Mar 2008 Genitope Corporation to Suspend Development of MyVax(R) Personalized Immunotherapy
10 Mar 2008 Oxford Biomedica completes patient recruitment for Phase III trist study of Trovax (R) in renal cancer
07 Mar 2008 THE LANCET publishes phase IIa study results with Cytos Biotechnology’s hypertension vaccine CYT006-AngQb
27 Feb 2008 Intercell completes Phase I clinical trial for improved seasonal Flu vaccine formulated with IC31(R)
27 Feb 2008 Circassia Initiates Phase II Clinical Study With Novel Anti-Allergy Technology
25 Feb 2008 GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials
25 Feb 2008 Acambis initiates pre-clinical testing with herpes vaccine from Harvard Medical School
20 Feb 2008 GlaxoSmithKline receives favourable recommendation by FDA Advisory Committee for Rotarix(R)
20 Feb 2008 Oxford Biomedica announces data safety monitoring board recommendation to continue TroVax (R) Phase III trist study
15 Feb 2008 Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
14 Feb 2008 Vaccine formulated with Intercell's adjuvant IC31(R) part of a broader collaboration to fight TB
12 Feb 2008 Iomai Study Shows Self-Applied Travelers' Diarrhea Vaccine Patch Comparable to Clinician-Applied Vaccine Patch
07 Feb 2008 Intercell's therapeutic Hepatitis C vaccine meets primary endpoints in Phase II
07 Feb 2008 GeoVax Labs, Inc.'s Promising HIV/AIDS Vaccine Trial Data Presented at Retrovirus Conference
22 Jan 2008 Medicago’s Pandemic Flu Vaccine Provides 100% Protection in Mice at Low Doses
16 Jan 2008 ICLL receives manufacturer's licence for future commercial manufacturing of its JE vaccine
16 Jan 2008 Intercell and PATH Malaria Vaccine Initiative Announce New Collaboration for Vaccine against Malaria
14 Jan 2008 Interim Analysis Supports Continuation of Cell Genesys' VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
14 Jan 2008 Nventa completes evaluation of second cohort in HSPE7 Phase 1 cervical dysplasia trial
09 Jan 2008 New data show Menveo(TM) to be the first quadrivalent meningococcal vaccine to provide immunogenicity in infants
07 Jan 2008 Celldex Therapeutics Receives Fast-Track Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma
03 Jan 2008 Acambis reports positive data from trials of universal influenza A vaccine
31 Dec 2007 IDM Pharma Announces Termination of UVIDEM Development Collaboration and Expected Restructuring in Connection With Evaluation of Strategic Alternatives
27 Dec 2007 Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
24 Dec 2007 Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
21 Dec 2007 Aeras and Crucell Announce Start of a Tuberculosis Vaccine Clinical Trial in the United States. Aeras commits a further USD 5 million to the development of the tuberculosis vaccine
21 Dec 2007 Curalogic announces top line results from Phase III clinical study with the
20 Dec 2007 Novavax Announces Favorable Interim Results From Human Clinical Trial
20 Dec 2007 Successful Collaboration between US Army and Intercell Towards a Novel Vaccine Against JE
20 Dec 2007 Genitope Corporation Reports Initial Results of Phase 3 Clinical Trial of MyVax(R) Personalized Immunotherapy
19 Dec 2007 GlobeImmune Announces Initiation of Phase II Clinical Trial of GI-5005 in Patients with Chronic Hepatitis C
17 Dec 2007 GlaxoSmithKline receives FDA 'complete response' letter for cervical cancer vaccine
17 Dec 2007 Lilly and BioMS Medical Announce Global Licensing and Development Agreement
16 Dec 2007 Intercell receives Milestone Payment from Merck & Co. Inc.
14 Dec 2007 IDM Pharma Provides Update of Product Pipeline and Announces Plans to Evaluate Strategic Alternatives for the Company
12 Dec 2007 Geron receives milestone payment from merck triggered by ind filing for telomerase cancer vaccine candidate
10 Dec 2007 Oxford Biomedica Announces Data Safety Monitoring Board Recommendation to ContinueTroVax(R) Phase III Trial in Renal Cancer
06 Dec 2007 Intercell Submits Marketing Authorization Application (MAA) to EMEA for Licensure of Japanese Enceph
06 Dec 2007 Nventa completes enrollment and initial dosing of second cohort in phase 1 hspE7 safety trial
06 Dec 2007 AVANT Immunotherapeutics Achieves Immune Responses Against Cholera, Typhoid and Enterotoxigenic E. coli with a Single-Dose, Oral Combination Vaccine
04 Dec 2007 SSI, Intercell and Aeras announce start of clinical trial for novel vaccine candidate against TB
29 Nov 2007 Cytos Biotechnology announces start of two phase II studies
29 Nov 2007 Bavarian Nordic A/S reports positive data from first EUA enabling study with IMVAMUNE(R) smallpox vaccine
28 Nov 2007 Oralair(R) Grasses: Positive results of VO52.06 paediatric study
27 Nov 2007 Nventa updates progress with new HspE7 in Phase 1 trial in cervical dysplasia
27 Nov 2007 Inovio Biomedical Partner Tripep Treats First Subject in Phase I/II Study of Novel Hepatitis C DNA Vaccine
23 Nov 2007 New data published in The Lancet show GSK's rotavirus vaccine Rotarix(R) offers sustained and broad protection against all common circulating rotavirus types
22 Nov 2007 Diamyd Executes Agreement With US National Institutes of Health For a Type 1 Diabetes Trial With The Experimental Diamyd(R) Diabetes Vaccine
21 Nov 2007 New promising results published on Pharmexa's PADRE(R) epitope in Alzheimer's vaccine
20 Nov 2007 Cytos Biotechnology presents encouraging phase IIa study results for its melanoma vaccine CYT004-MelQbG10
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 101 - 150 of 601

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Toll-Like Receptor (TLR) Agonists & Antagonists

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics